T13 — Chapel Hill, North Carolina

T13 is a clinical research site located in Chapel Hill, North Carolina, United States 27599.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

T13 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Antisynthetase Syndrome.

Sponsors: Cartesian Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chapel Hill

Browse all research sites in North Carolina · View every site in Chapel Hill

• UNC Hospitals Adult Oncology Clinics
• University of North Carolina School of Medicine - Center for Infectious Diseases
• University of North Carolina
• University of North Carolina Health Care - Infectious Diseases
• University of North Carolina, Chapel Hill - Female Pelvic Medicine and Reconstructive Surgery
• University of North Carolina Children's Hospital
• Site 22: University of North Carolina
• University of North Carolina at Chapel Hill, Hemophilia and Thrombosis Center
• University of North Carolina Healthcare
• UNC Health - University of North Carolina
• University of North Carolina Orhthopedics
• University of North Carolina (UNC) Memorial Hospital

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for T13?

T13 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has T13 conducted?

T13 has 1 clinical trials on record, with 1 currently active. Their work covers Antisynthetase Syndrome.

Is T13 accredited by Crixeo Clinical Trials?

T13 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about T13?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.